日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ineffectiveness of Sotatercept Therapy in a Patient With Heritable Pulmonary Arterial Hypertension Associated With a Previously Unreported Missense Variant in GDF2, the Gene for Bone Morphogenic Protein-9

索他西普治疗对一名患有遗传性肺动脉高压的患者无效,该患者携带先前未报道的GDF2基因(骨形态发生蛋白-9基因)错义变异。

Langleben, David; Lesenko, Lyda; Fox, Benjamin D; Eintracht, Shaun; Foulkes, William D; Rosenblatt, David S

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study

肺动脉高压患者从肠外前列腺素类药物过渡到口服司来帕格:一项多中心回顾性队列研究

Budhram, Brandon; Alrasheed, Sarah K; Rashad, Moaaz; Chandy, George; Dvorkin-Gheva, Anna; Fox, George A; Foxall, Julia; Gardner, Andrea; Helmersen, Doug; Hirani, Naushad; Kemp, Kristina; Kularatne, Mithum; Langleben, David; Lesenko, Lyda; Provencher, Steeve; Spence, Emma; Swiston, John R; Thakrar, Mitesh; Wadden, Daniel; Weatherald, Jason; Hambly, Nathan

Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension

右心室ST段抬高型心肌梗死是特发性肺动脉高压患者的死亡原因之一

Zhan, Yang; Burstein, Barry; Abualsaud, Ali O; Nosair, Mohamed; Hirsch, Andrew M; Lesenko, Lyda; Langleben, David

Pregnancy as a possible trigger for heritable pulmonary arterial hypertension

妊娠可能是遗传性肺动脉高压的诱发因素

Limoges, Maude; Langleben, David; Fox, Benjamin D; Shear, Roberta; Wieczorek, Paul; Rudski, Lawrence G; Hirsch, Andrew M; Schlesinger, Robert D; Lesenko, Lyda